Roche, Ionis RNA drug scores in kidney disease study

Data ReadoutpositivePositive

AI Analysis

Summary

Roche and Ionis' RNA drug demonstrated positive results in a kidney disease study for IgA nephropathy, positioning the companies to bring a new therapeutic option to market for this indication.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

RNA drug scores in kidney disease study

Importance:7/10

Sentiment:

0.75

IgA nephropathyRNA therapeuticclinical trialpartnership

Related Companies

$RHHBY $IONS

Read the original article

Published by BioPharma Dive on September 23, 2026 4:21 PM

Read Original